23-03 Dr. Rob Ross, CEO, Surface Oncology
- Author
- Moira Gunn
- Published
- Sun 15 Jan 2023
- Episode Link
- https://share.transistor.fm/s/d49b7b7d
Surface Oncology's strategy to improve on the first generation of immuno-oncology drugs. Their Phase 2 trials in lung cancer and liver cancer are underway and recruiting.
